Article
First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency).
Journal of clinical pharmacy and therapeutics - 1 Feb 2018
Kose E, Kuyum P, Aksoy B, Häberle J, Arslan N, Ozturk Y
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Carglumic acid is a structural analogue of human N-acetylglutamate, which has become an alternative therapeutic option for hyperammonaemia in organic acidaemias such as isovaleric acidaemia, methylmalonic acidaemia and propionic acidaemia, and it has been suggested in other urea cycle disorders such as ornithine transcarbamylase deficiency and carbamoyl phosphate synthetase 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
